Advertisement

Advertisement

AMPH Stock Latest News

Amphastar Earnings Call Balances Growth and Margin Strain

Company AnnouncementsAmphastar Earnings Call Balances Growth and Margin Strain

Amphastar downgraded to Equal Weight from Overweight at Wells Fargo

PremiumThe Fly

Amphastar downgraded to Equal Weight from Overweight at Wells Fargo

13d ago

Amphastar price target lowered to $21 from $25 at Piper Sandler

PremiumThe Fly

Amphastar price target lowered to $21 from $25 at Piper Sandler

16d ago

Amphastar Balances Margin Pain With Pipeline Gains

PremiumCompany Announcements

Amphastar Balances Margin Pain With Pipeline Gains

19d ago

Amphastar downgraded to Hold from Buy at Needham

PremiumThe Fly

Amphastar downgraded to Hold from Buy at Needham

19d ago

Amphastar cut to Hold at Needham after ‘disappointing’ results

PremiumThe FlyAmphastar cut to Hold at Needham after ‘disappointing’ results

19d ago

Amphastar reports Q1 EPS 42c, consensus 71c

The Fly

Amphastar reports Q1 EPS 42c, consensus 71c

19d ago

Amphastar Pharmaceuticals Inc (AMPH) Q1 Earnings Cheat Sheet

Pre-Earnings

Amphastar Pharmaceuticals Inc (AMPH) Q1 Earnings Cheat Sheet

22d ago

Amphastar downgraded to Hold from Buy at Jefferies

PremiumThe Fly

Amphastar downgraded to Hold from Buy at Jefferies

1M ago

Amphastar price target lowered to $23 from $30 at Barclays

PremiumThe Fly

Amphastar price target lowered to $23 from $30 at Barclays

2M ago

Amphastar Expands Share Repurchase Authorization to Manage Equity

PremiumCompany Announcements

Amphastar Expands Share Repurchase Authorization to Manage Equity

2M ago

Amphastar Updates Executive Employment Agreements to Strengthen Leadership

PremiumCompany Announcements

Amphastar Updates Executive Employment Agreements to Strengthen Leadership

3M ago

Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks

PremiumCompany AnnouncementsAmphastar Pharmaceuticals Balances Growth Plans With Margin Risks

3M ago

Amphastar price target lowered to $30 from $34 at Wells Fargo

The Fly

Amphastar price target lowered to $30 from $34 at Wells Fargo

3M ago

Amphastar reports Q4 EPS 73c, consensus 92c

The Fly

Amphastar reports Q4 EPS 73c, consensus 92c

3M ago

Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA

PremiumThe Fly

Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA

3M ago

AMPH Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

AMPH Upcoming Earnings Report: What to Expect?

3M ago

Amphastar Licenses ACTH Analog AMP-110 for North America

PremiumCompany Announcements

Amphastar Licenses ACTH Analog AMP-110 for North America

4M ago

Amphastar price target lowered to $30 from $31 at BofA

PremiumThe Fly

Amphastar price target lowered to $30 from $31 at BofA

5M ago

Amphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015

PremiumRatingsAmphastar Pharmaceuticals Receives Buy Rating Following FDA Approval of AMP-015

5M ago

Amphastar announces FDA approval for teriparatide injection

The Fly

Amphastar announces FDA approval for teriparatide injection

5M ago

Amphastar initiated with an Equal Weight at Barclays

The Fly

Amphastar initiated with an Equal Weight at Barclays

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >